CareMax downgraded to market perform at Cowen on challenging full-risk, EBITDA projections

Mar. 17, 2023 1:51 PM ETCareMax, Inc. (CMAX)By: Jonathan Block, SA News Editor

People on busy Wall street in Manhattan


  • Cowen has downgraded CareMax (NASDAQ:CMAX) to market perform from outperform saying that the company's ambitious plan to boost full-risk lives and improve EBITDA could prove challenging.
  • The firm also cut its price target to $4 from $7 (~10% upside based on

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.